ACM
DRUG

ADAR1 Capital Management’s Bright Minds Biosciences DRUG Stock Holding History

ADAR1 Capital Management’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Sell
30,300
-3,600
-11% -$283K 0.1% 140
2026
Q1 		$2.47M Buy
33,900
+30,400
+869% +$2.45M 0.15% 116
2025
Q4 		$273K Buy
+3,500
New +$234K 0.02% 212

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

ADAR1 Capital Management's DRUG Position: Q2 2026 in Review

ADAR1 Capital Management reduced its Bright Minds Biosciences (DRUG) stake by 11% in Q2 2026, selling an estimated $283K and leaving 30,300 shares worth $2.13M. The position accounts for 0.1% of the portfolio, ranked #140.

ADAR1 Capital Management first reported a position in DRUG in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.47M in Q1 2026. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • ADAR1 Capital Management held 30,300 shares of Bright Minds Biosciences worth $2.13M as of Q2 2026.
  • ADAR1 Capital Management sold 3,600 Bright Minds Biosciences shares in Q2 2026, an estimated $283K.
  • Bright Minds Biosciences made up 0.1% of ADAR1 Capital Management's portfolio in Q2 2026, its #140 holding.
  • ADAR1 Capital Management first reported a position in Bright Minds Biosciences in Q4 2025 and has held it in 3 quarters since.
  • ADAR1 Capital Management's Bright Minds Biosciences position peaked at $2.47M in Q1 2026.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.